|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2005-11-18
|
|
pubmed:abstractText |
Although endothelin I (ET-1) is a very potent vasoconstrictor, ET-1 transgenic (ET-1 tg) mice are not hypertensive. This might be due to higher bioavailability of nitric oxide (NO) in ET-1 tg, which counteracts the effect of vasoconstrictors. We hypothesized lower angiotensin II (Ang II) sensitivity of afferent arterioles in ET-1 tg.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II,
http://linkedlifedata.com/resource/pubmed/chemical/Endothelin-1,
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/NG-Nitroarginine Methyl Ester,
http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Synthase,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Angiotensin,
http://linkedlifedata.com/resource/pubmed/chemical/Renin,
http://linkedlifedata.com/resource/pubmed/chemical/Vasoconstrictor Agents
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0931-0509
|
|
pubmed:author |
pubmed-author:BontschoJuliaJ,
pubmed-author:GodesMichaelM,
pubmed-author:HocherBertholdB,
pubmed-author:JoehrenOlafO,
pubmed-author:KupschEckehardtE,
pubmed-author:LaiEnyinE,
pubmed-author:PatzakAndreasA,
pubmed-author:RichterClaus-MichaelCM,
pubmed-author:SkalweitAngelaA,
pubmed-author:SteegeAndreasA,
pubmed-author:Thöne-ReinekeChristaC,
pubmed-author:ZimmermannMathiasM
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2681-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16188896-Angiotensin II,
pubmed-meshheading:16188896-Animals,
pubmed-meshheading:16188896-Blood Pressure,
pubmed-meshheading:16188896-Disease Models, Animal,
pubmed-meshheading:16188896-Endothelin-1,
pubmed-meshheading:16188896-Enzyme Inhibitors,
pubmed-meshheading:16188896-Gene Expression,
pubmed-meshheading:16188896-Kidney Glomerulus,
pubmed-meshheading:16188896-Male,
pubmed-meshheading:16188896-Mice,
pubmed-meshheading:16188896-Mice, Transgenic,
pubmed-meshheading:16188896-NG-Nitroarginine Methyl Ester,
pubmed-meshheading:16188896-Nitric Oxide Synthase,
pubmed-meshheading:16188896-Polymerase Chain Reaction,
pubmed-meshheading:16188896-RNA, Messenger,
pubmed-meshheading:16188896-Receptors, Angiotensin,
pubmed-meshheading:16188896-Renal Artery,
pubmed-meshheading:16188896-Renin,
pubmed-meshheading:16188896-Vasoconstriction,
pubmed-meshheading:16188896-Vasoconstrictor Agents
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Angiotensin II sensitivity of afferent glomerular arterioles in endothelin-1 transgenic mice.
|
|
pubmed:affiliation |
Johannes-Müller-Institut für Physiologie, Humboldt-Universität zu Berlin, Universitätsklinikum Charité, Tucholskystr. 2, 10117 Berlin. andreas.patzak@charite.de
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
In Vitro,
Research Support, Non-U.S. Gov't
|
